Lipid peroxidation in the pathogenesis of neuroborreliosis

Free Radical Biology and Medicine

Volumn 96, Issue , 2016, Pages 255-263

  Moniuszko Malinowska, Anna ^a   Łuczaj, Wojciech ^a   Jarocka Karpowicz, Iwona ^a   Pancewicz, Sławomir ^a   Zajkowska, Joanna ^a   Andrisic, Luka ^b   Zarkovic, Neven ^b   Skrzydlewska, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

4 Hydroxy 2 nonenal; CSF; F2 isoprostaneas; Fattyacids; Lipid peroxidation; Neuroborreliosis; Neuroprostanes; Phospholipases; Plasma; Reactivealdehydes; Urine

Indexed keywords

4-HYDROXY-2-NONENAL; 4-HYDROXYHEXENAL; ALDEHYDE; CEFTRIAXONE; DOCOSAHEXAENOIC ACID; GLUTATHIONE PEROXIDASE; ISOPROSTANE DERIVATIVE; MALONALDEHYDE; PHOSPHOLIPASE A2;

ADULT; AGED; BLOOD; BORRELIA BURGDORFERI; CEREBROSPINAL FLUID; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; LIPID PEROXIDATION; LYME NEUROBORRELIOSIS; MALE; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; PATHOGENICITY; URINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALDEHYDES; BORRELIA BURGDORFERI; CEFTRIAXONE; DOCOSAHEXAENOIC ACIDS; F2-ISOPROSTANES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDATION; LYME NEUROBORRELIOSIS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PHOSPHOLIPASES A2;

EID: 84967166457     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2016.04.032     Document Type: Article

References (69)

1. B.A. Fallon, J.A. Nields, J.J. Burrascano, K. Liegner, D. DelBene, and M.R. Liebowitz The neuropsychiatric manifestations of Lyme borreliosis Psychiatr. Q. 63 1992 41 63
2. J.J. Halperin, and M.P. Heyes Neuroactive kynurenines in Lyme borreliosis Neurology 42 1992 43 50
3. H. Baran, B. Kepplinger, and M. Draxler Endogenous kynurenine aminotransferases inhibitor is proposed to act as "Glia Depressing Factor" (GDF) Int. J. Tryptophan Res. 3 2010 13 22
4. D. Fuchs, L. Dotevall, L. Hagberg, E. Werner, and H. Wachter Kynurenine in cerebrospinal fluid of patients with Lyme neuroborreliosis Immunol. Infect. Dis. 1 1991 271 274
5. T.W. Stone, and L.G. Darlington Endogenous kynurenines as targets for drug discovery and development Nat. Rev. Drug Discov. 1 2002 609 620
6. J.A. Joseph, B. Shukitt-Hale, G. Casadesus, and D. Fisher Oxidative stress and inflammation in brain aging: nutritional considerations Neurochem. Res. 30 2005 927 935
7. Q. Li, N.Y. Spencer, N.J. Pantazis, and J.F. Engelhardt Alsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicity J. Biol. Chem. 286 2011 40151 40162
8. S.M.H. Sadrzadeh, and Y. Saffari Iron and brain disorders Am. J. Clin. Pathol. 121 2004 64 70
9. S. Shila, V. Kokilavani, M. Subathra, and C. Panneerselvam Brain regional responses in antioxidant system to alpha-lipoic acid in arsenic intoxicated rat Toxicology 210 2005 25 36
10. S.A. Pancewicz, T. Hermanowska-Szpakowicz, M. Makarewicz-Płońska, A. Witek, R. Farbiszewski, J. Zajkowska, and et al. Decreased antioxidant-defence mechanisms in cerebrospinal fluid (CSF) in patients with tick-borne encephalitis (TBE) Neurol. Neurochir. Pol. 36 2002 767 776
11. M. Kerman, B. Cirak, F.M. Ozguner, A. Dagtekin, R. Sutcu, I. Altuntas, and et al. Does melatonin protect or treat brain damage from traumatic oxidative stress? Exp Brain Res. 163 2005 406 410
12. D.E. Paglia, and W.N. Valentine Studies on the quantitative and qualitative characterization of erytrocyte glutathione peroxidase J. Lab. Clin. Med. 70 1967 158 169
13. A. De Leenher, V. De Bevere, M.G. De Ruyter, and A.C. Claeys Simultaneous determination of retinol and α-tocopherol in human serum by HPLC J. Chromatogr. 162 1979 408 413
14. W.W. Christie Preparation of ester derivatives of fatty acids for chromatographic analysis W.W. Christie, Advances in Lipid Methodology - Two 1993 Oily Press Dundee 69 111
15. X.P. Luo, M. Yazdanpanah, N. Bhooi, and D.C. Lehotay Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry Anal. Biochem. 228 1995 294 298
16. S.A. Coolen, B. van Buuren, G. Duchateau, J. Upritchard, and H. Verhagen Kinetics of biomarkers: biological and technical validity of isoprostanes in plasma Amino Acids 29 2005 429 436
17. S.S. Fam, L.J. Murphey, E.S. Terry, W.E. Zackert, Y. Chen, L. Gao, and et al. Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-neuroprostanes) in vivo from docosahexaenoic acid J. Biol. Chem. 277 2002 36076 36084
18. W. Łuczaj, A. Moniuszko, M. Rusak, S. Pancewicz, J. Zajkowska, and E. Skrzydlewska Lipid peroxidation products as potential bioindicators of Lyme arthritis Eur. J. Clin. Microbiol. Infect. Dis. 30 2011 415 422
19. D. Weber, L. Milkovic, S.J. Bennett, H.R. Griffiths, N. Zarkovic, and T. Grune Measurement of HNE-protein adducts in human plasma and serum by ELISA - Comparison of two primary antibodies Redox Biol. 1 2013 226 233
20. S. Borovic, F. Rabuzin, G. Waeg, and N. Zarkovic Enzyme-linked immunosorbent assay for 4-hydroxynonenal-histidine conjugates Free Radic. Res. 40 2006 809 820
21. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
22. J.J. Halperin Lyme disease: a multisystem infection that affects the nervous system Continuum 18 2012 1338 1350
23. R. Kaiser Neuroborreliosis J. Neurol. 245 1998 247 255
24. T.A. Rupprecht, U. Koedel, V. Fingerle, and H.W. Pfister The pathogenesis of lyme neuroborreliosis: from infection to inflammation Mol. Med. 14 2008 205 212
25. A.R. Pachner, and I. Steiner Lyme neuroborreliosis: infection, immunity, and inflammation Lancet Neurol. 6 2007 544 552
26. A. Rasley, J. Anguita, and I. Marriott Borrelia burgdorferi induces inflammatory mediator production by murine microglia J. Neuroimmunol. 130 2002 22 31
27. M. Widhe, S. Jarefors, C. Ekerfelt, M. Vrethem, S. Bergstrom, P. Forsberg, and et al. Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome J. Infect. Dis. 189 2004 1881 1891
28. T. Cerar, K. Ogrinc, S. Lotric-Furlan, J. Kobal, S. Levicnik-Stezinar, F. Strle, and et al. Diagnostic value of cytokines and chemokines in lyme neuroborreliosis Clin. Vaccine Immunol. 20 2013 1578 1584 10.1128%2FCVI.00353-13
29. A. Moniuszko, S.A. Pancewicz, P. Czupryna, S. Grygorczuk, R. Świerzbińska, M. Kondrusik, and et al. ssICAM-1, IL-21 and IL-23 in patients with tick borne encephalitis and neuroborreliosis Cytokine 60 2012 468 472
30. D. Closa, and E. Folch-Puy Oxygen free radicals and the systemic inflammatory response IUBMB Life 56 2004 185 191
31. J. Schenck Pathophysiology of brain iron Proc. Intl. Soc. Mag. Reson. Med. 18 2010 1 8
32. A.M. Enciu, M. Gherghiceanu, and B.O. Popescu Triggers and effectors of oxidative stress at blood-brain barrier level: relevance for brain ageing and neurodegeneration Oxid. Med. Cell. Longev. 2013 2013 297512 10.1155/2013/297512
33. P. Wang, P. Dadhwal, Z. Cheng, M.R. Zianni, Y. Rikihisa, F.T. Liang, and et al. Borrelia burgdorferi oxidative stress regulator BosR directly represses lipoproteins primarily expressed in the tick during mammalian infection Mol. Microbiol. 89 2013 1140 1153
34. H.Y. Kim, M. Akbar, and Y.S. Kim Prostaglandins Leukot. Essent. Fatty Acids 2-3 2010 165
35. J.H. Song, K. Fujimoto, and T. Miyazawa Polyunsaturated (n-3) fatty acids susceptible to peroxidation are increased in plasma and tissue lipids of rats fed docosahexaenoic acid-containing oils J. Nutr. 130 2000 3028 3033
36. P. Montuschi, P.J. Barnes, and L.J. Roberts 2nd Isoprostanes: markers and mediators of oxidative stress FASEB J. 18 2004 1791 1800
37. E. Miller, A. Morel, L. Saso, and J. Saluk Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases Oxid. Med. Cell. Longev. 2014 2014 572491 10.1155/2014/572491
38. 2-isoprostanes in Alzheimer and other neurodegenerative diseases Antioxid. Redox Signal. 7 2005 269 275
39. W. Łuczaj, A. Moniuszko, I. Jarocka-Karpowicz, S. Pancewicz, L. Andrisic, N. Zarkovic, and E. Skrzydlewska Tick-borne encephalitis - lipid peroxidation and its consequences Scand. J. Clin. Lab. Invest. 28 2015 1 9
40. W. Łuczaj, A. Moniuszko, M. Rusak, J. Zajkowska, S. Pancewicz, and E. Skrzydlewska Peroxidative metabolism of arachidonic acid in the course of Lyme arthritis Ann. Agric. Environ. Med. 22 2015 433 437
41. W. Łuczaj, A. Moniuszko, M. Rusak, S. Pancewicz, J. Zajkowska, and E. Skrzydlewska Lipid peroxidation products as potential bioindicators of Lyme arthritis Eur. J. Clin. Microbiol. Infect. Dis. 30 2011 415 422
42. J.L. Cracowski, T. Durand, and G. Bessard Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications Trends Pharmacol. Sci. 23 2002 360 366
43. M.C. Irizarry, and B.T. Hyman Brain isoprostanes: a marker of lipid peroxidation and oxidative stress in AD Neurology 61 2003 436 437
44. 2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention Chem. Rev. 111 2011 6130 6185
45. J.M. Foulks, G.K. Marathe, N. Michetti, D.M. Stafforini, G.A. Zimmerman, T.M. McIntyre, and et al. PAF-acetylhydrolase expressed during megakaryocyte differentiation inactivates PAF-like lipids Blood 113 2009 6699 6706
46. T.M. McIntyre, S.M. Prescott, and D.M. Stafforini The emerging roles of PAF acetylhydrolase J. Lipid Res. 50 2009 255 259
47. V.A. Blaho, W.J. Mitchell, and C.R. Brown Arthritis develops but fails to resolve during inhibition of cyclooxygenase 2 in a murine model of Lyme disease Arthritis Rheum. 58 2008 1485 1495
48. W. Łuczaj, A. Moniuszko, M. Rusak, J. Zajkowska, S. Pancewicz, and E. Skrzydlewska Peroxidative metabolism of arachidonic acid in the course of Lyme arthritis Ann. Agric. Environ. Med. 22 2015 433 437
49. J.A. Berliner, N. Leitinger, and S. Tsimikas The role of oxidized phospholipids in atherosclerosis J. Lipid Res. 50 Suppl. 2009 S207 S212
50. G. Subbanagounder, J.W. Wong, H. Lee, K.F. Faull, E. Miller, J.L. Witztum, and et al. Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta J. Biol. Chem. 277 2002 7271 7281
51. N.M. Gharavi, J.A. Alva, K.P. Mouillesseaux, C. Lai, M. Yeh, W. Yeung, and et al. Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo J. Biol. Chem. 282 2007 31460 31468
52. H.K. Jyrkkänen, E. Kansanen, M. Inkala, A.M. Kivelä, H. Hurttila, S.E. Heinonen, and et al. Nrf2 regulates antioxidant gene expression evoked by oxidized phospholipids in endothelial cells and murine arteries in vivo Circ. Res. 103 2008 e1 e9 10.1161/CIRCRESAHA.108.176883
53. O.H. Lee, A.K. Jain, V. Papusha, and A.K. Jaiswal An auto-regulatory loop between stress sensors INrf2 and Nrf2 controls their cellular abundance J. Biol. Chem. 282 2007 36412 36420
54. K.S. Fritz, and D.R. Petersen An overview of the chemistry and biology of reactive aldehydes Free Radic. Biol. Med. 59 2013 85 91
55. F. Gueraud, M. Atalay, N. Bresgen, A. Cipak, P.M. Eckl, L. Huc, and et al. Chemistry and biochemistry of lipid peroxidation products Free Radic. Res. 44 2010 1098 1124
56. S.L. Hazen Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity J. Biol. Chem. 283 2008 15527 15531
57. A. Catala Lipid peroxidation of membrane phospholipids generates hydroxyalkenals and oxidized phospholipids active in physiological and/or pathological conditions Chem. Phys. Lipids 157 2009 1 11
58. J.C. Ullery, and L.J. Marnett Protein modification by oxidized phospholipids and hydrolytically released lipid electrophiles: investigating cellular responses Biochim. Biophys. Acta 1818 2012 2424 2435
59. I.V.J. Murray, L. Liu, H. Komatsu, K. Uryu, G. Xiao, J.A. Lawson, and et al. Membrane mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins J. Biol. Chem. 282 2007 9335 9345
60. C.M. Lauderback, J.M. Hackett, F.F. Huang, J.N. Keller, L.I. Szweda, W.R. Markesbery, and et al. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of A beta 1-42 J. Neurochem. 78 2001 413 416
61. D.A. Butterfield, M.L.B. Lange, and R. Sultana Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease Biochim. Biophys. Acta 1801 2010 924 929
62. A. D'Souza, B.T. Kurien, R. Rodgers, J. Shenoi, S. Kurono, H. Matsumoto, and et al. Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE BMC Med. Genet. 9 2008 62 10.1186/1471-2350-9-62
63. N. Makhani, S.K. Morris, A.V. Page, J. Brophy, J.R. Lindsay, B.L. Banwell, and et al. A twist on Lyme: the challenge of diagnosing european Lyme neuroborreliosis J. Clin. Microbiol. 49 2011 455 457
64. G. Ramesh, A.G. MacLean, and M.T. Philipp Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain Mediat. Inflamm. 2013 2013 480739
65. B.J. Luft, C.R. Steinman, H.C. Neimark, B. Muralidhar, T. Rush, M.F. Finkel, and et al. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection JAMA 267 1992 1364 1367
66. A. Moniuszko, S.A. Pancewicz, M. Kondrusik, J. Zajkowska, S. Grygorczuk, and R. Swierzbińska Concentration of soluble forms of selectins in serum and in cerebrospinal fluid in group of patients with neuroborreliosis - a preliminary study Pol. Merkur. Lekarski 23 2007 174 178
67. S.A. Pancewicz, M. Kondrusik, J. Zajkowska, and S. Grygorczuk Concentrations of pro-inflammatory cytokines IFN-gamma, IL-6, IL-12 and IL-15 in serum and cerebrospinal fluid in patients with neuroborreliosis undergoing antibiotic treatment Pol. Merkur. Lekarski 22 2007 275 279
68. B. Uttara, A.V. Singh, P. Zamboni, and R.T. Mahajan Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options Curr. Neuropharmacol. 7 2009 65 74
69. J. Frijhoff, P.G. Winyard, N. Zarkovic, S. Davies, R. Stocker, D. Cheng, A. Knight, E.L. Taylor, J. Oettrich, T. Ruskovska, A. Cipak Gasparovic, A. Cuadrado, D. Weber, H.E. Poulsen, T. Grune, H.H. Schmidt, and P. Ghezzi Clinical relevance of biomarkers of oxidative stress Antioxid. Redox Signal. 23 2015 1144 1170